Obesity · High-fat diet · Metabolic syndrome · CES1 · APOE · Lipid metabolism Summary Objective: The aim of the present study was to investigate the relationship between the differential expression of genes related to lipid metabolism in subcutaneous adipose tissue and metabolic syndrome features in lean and obese subjects with habitual high fat intake. Methods: Microarray and RT-PCR analysis were used to analyze and validate differential gene expression in subcutaneous abdominal adipose tissue samples from lean and obese phenotype subjects. Results: Several genes and transcripts involved in lipolysis were down-regulated, such as AKAP1, PRKAR2B, Gi and CIDEA, whereas NPY1R and CES1 were up-regulated, when comparing obese to lean subjects. Similarly, transcripts associated with cholesterol and lipoprotein metabolism showed a differential expression, with APOE and ABCA being decreased and VLDLR being increased in obese versus lean subjects. In addition, positive correlations were found between different markers of the metabolic syndrome and CES1 and NPY1R mRNA expressions, while APOE showed an inverse association with some of them. Conclusion: Different expression patterns in transcripts encoding for proteins involved in lipolysis and lipoprotein metabolism were found between lean and obese subjects. Moreover, the dysregulation of genes such as CES1 and APOE seems to be associated with some physiopathological markers of insulin resistance and cardiovascular risk factors in obesity.
Introduction
Adiposetissueplaysacriticalroleinenergyhomeostasisby hydrolyzing triacylglycerol reserves to provide fatty acids, whichareimportantoxidativefuelsforothertissuesinsituationsofenergydemandsuchasfastingandexercise [1] .Thus, afineregulationoflipolysisiscrucialforthemaintenanceof bodyenergyhomeostasisaswellasforthepreventionofmetabolicdiseases.Indeed,excessfataccumulationisassociated withaconstellationofmetabolicriskfactorsrelatedtocardiovasculardiseaseandtype2diabetes,mainlyduetoadisproportionate release of fatty acids and an impairment in the secretionofadipokines [2] .Ontheotherhand,lipodystrophy mayalsoleadtophysiopathologicalalterationsoftenaccompanying the metabolic syndrome [3] . The common link between both diseases may be a defective storage capacity in adiposetissuedepots:inthecaseoflipodystrophyduetolack ofproperamountofadiposetissueandinthecaseofobesity duetosaturationofstoragecapacity [4] .Thus,thefunctional failureoftheadiposetissuetobufferpostprandiallipidsdue to a chronically disturbed energy balance could result in changesinadipokinesecretionandvasculareffectsthatinfluencesthebodyhomeostasissystem,whichhasbeenproposed as an explanation of the metabolic syndrome [5] . Furthermore,variationsinthenatureandmagnitudeoftheappearanceofthemetabolicsyndromemanifestationsareattributable to the interaction of genetic factors with environmental influences,mostnotablydietandphysicalactivity [6, 7] .
In this context, we investigated the relationship between the expression of several genes related to lipid metabolism andmetabolicsyndromefeaturesintwophenotypicallywell characterizedgroupsofsubjects [8] thatsignificantlydiffered withrespecttobodyweightdespitereportingsimilardailyfat intakeandphysicalactivitypatterns;onegroupofvolunteers remained lean and with no features of metabolic syndrome ObesFacts2010; 3:312-318 DysregulationinAdiposeLipidMetabolism GenesandObesity 313 and the other group was obese. Indeed, elucidating differencesingeneexpressioninthesubcutaneousabdominaladipose tissue (SCAAT) from these two groups of volunteers could help to develop therapies to prevent metabolic syndrome.
Subjects and Methods

Study Design and Subjects
Ninelean(22-33yearsold)and9age-matchedobesehigh-fatconsumers (21-35 years old) were recruited as previously described, using a validatedquestionnairebasedonself-reportedquestionsaboutlifestyleand foodfrequencyconsumption [8] .Allsubjectswerehealthy,non-diabetic, non-hyperlipidemicmalestakingnooralmedicationsandshowingastablebodyweightduringatleasttheprevious3months.Inordertoconfirm thattheamountandcompositionofenergyingestedwas>40%fromfat, eachsubjectcompleteda3-dayweighedfoodrecordfor2weekdaysand 1weekendday.Thefoodrecordswereanalyzedbyatrainednutritionist usingacomputerizedprogram(Medisystem,SanoCare,Madrid,Spain). To quantify the level of physical activity, each participant completed a validatedquestionnaire [9] basedonself-reportedquestionsabouttheir leisuretimeandtheirworktimephysicalactivitiesonatypicalworkday and on a typical weekend day. In addition, sedentary lifestyle was assessedthroughthenumberofhoursperweekspentsittingdown(watchingTVorvideos,readingorlisteningtomusic,etc.)onatypicalworkday andonatypicalweekendday.Allvolunteersremainedlivinginthesame conditionsduringatleastthelast3years.
Anthropometrical Measurements and Adipose Tissue Biopsy
Ontheexperimentalday,volunteersarrivedattheClinicaUniversidad deNavarraafter12hofovernightfast.Anthropometricalmeasurements weremadeusingstandardproceduresaspreviouslydescribed [8] .Then, biopsies of SCAAT (1-2 g) were performed by liposuction under local anesthesia.ThesampleswerewashedandsoakedinRNA-later(Qiagen, Valencia, CA, USA) to avoid RNA degradation and then stored at -80ºCuntilutilization.TheprotocolwasapprovedbytheEthicalCommitteeoftheUniversityofNavarrameetingthestandardsoftheDeclarationofHelsinki [10] ,andallsubjectsgavetheirwritteninformedconsent beforeparticipatinginthestudy.
Blood Pressure and Measurements
Blood pressure (systolic and diastolic) was measured with a standard mercurysphygmomanometer(MinimusII,Riester,Jungingen,Germany) after the subject was quietly sitting for 5 min following WHO criteria. Fastingbloodmeasurementsweremadebystandardproceduresaspreviously described [8] . The quantitative insulin sensitivity check index (QUICKI)wasdeterminedusingtheinverseofthesumofthelogarithms ofthefastinginsulin(mU/ml)andfastingglucose(mg/dl).
RNA Preparation
Total RNA was isolated from each human SCAAT sample (including adipocytes and stroma-vascular fraction) by homogenization with an ultra-turrax ® T25basicusingTRIzol(LifeTechnologies,Gaithersburg, MD,USA)accordingtothemanufacturer'sinstructionsandincubated with RNase-free DNase (Ambion, Austin, TX, USA) for 30 min at 37°C.RNAconcentrationwasmeasuredspectrophotometrically,andits quality was verified by ethidium bromide staining after agarose gel electrophoresis.
Microarray Experiments and Analysis
RNAwaspooledtominimizethebiologicalvariationbetweentheindividualleanandobesesubjects.Thus,15mgoftotalRNAfromtwopools of3leansubjectseach(L1andL2)andtwootherfrom3obeseindividu-alseach(O1andO2)wereusedinthestandardprotocolfromAffymetrix to label targets. These targets (biotinylated complementary RNA) were hybridized to the Human HG-U133 A GeneChip arrays (Affymetrix; Santa Clara, CA, USA) at Progenika Biopharma Inc. (DerioVizcaya,Spain),usingtoolsobtainedfromAffymetrixandaccordingto the manufacturer's protocol (Affymetrix). Thus, a total of 4 array hybridizations were performed. The obtained signal values were further analyzedwiththeAffymetrixmicroarraysuite5.0.software(MAS5.0) system to examine obesity-dependent increases and decreases in gene expression.Afterglobalscaling,thesignaldetection,thesignallogratio (SLR)andthedifferentcallchangewerecalculatedandcomparedbetweenGeneChips.Thecomparisonwasperformedforallfourcombinations:obeseversusleansamples;O1versusL1,O1versusL2;O2versus L1;O2versusL2inadouble-crossanalysis(concordanceanalysis).The alteration ratios of the gene expression were represented as means of SLRofthefourquotients [11] .
GARBAN software [12, 13] was used to classify the differentially expressedgenesaccordingtoGeneOntologybiologicalprocesscriteria.
Real-Time PCR Analysis
Differentialgeneexpressionwasfurtherconfirmedbyreal-timePCRofa subsetofgenesinindividualsamples(n=9ineachgroup).Reagentsfor real-timePCRanalysisofAKAP1, NPY1R, CES1, APOE, VLDLRand 18S (Assays-on-Demand, TaqMan Reverse Transcriptase reagents, and TaqManUniversalPCRMastermix)werepurchasedfromAppliedBiosystems(FosterCity,CA,USA)andusedaccordingtothemanufacturer'sprotocol.Amplificationanddetectionofspecificproductswereperformed with the ABI PRISM 7000HT system (Applied Biosystems). Human18Swasusedasreferencetonormalizetheexpressionlevelsbe-tweensamples,allowingdatatobeexpressedrelativeto18SrRNAand thuscompensatingforanydifferencesinreversetranscriptaseefficacy,as previouslydescribed [11] . 
Statistical Analysis
Results
Baseline Characteristics of Lean and Obese Subjects
Notsurprisinglywithrespecttothestudydesign,BMI,waist circumference and waist-to-height ratio were significantly higher in obese than in lean subjects. Insulin sensitivity revealedbyQUICKI wassignificantlylowerinobesecompared toleansubjects.Thefastinglipidprofile,includingtriglycerides, total cholesterol and total / high-density lipoprotein (HDL) cholesterol ratio, was significantly higher in obese than in lean participants. The systolic and diastolic blood pressure values were significantly elevated in obese when comparedtoleansubjects.Moreover,theamountofleptinin blood was higher in obese subjects, while adiponectin was lower (table 1) . Even though high-fat diet is associated with presenceofthemetabolicsyndrome,leanvolunteersshowed nofeaturesofmetabolicsyndrome.AccordingtotheNational
Microarray Data
The analysis of the microarray data revealed that several relevanttranscriptsinvolvedinlipidmetabolismweredifferentially expressed in SCAAT of obese and lean subjects (table2).Somegenesinvolvedinthehormonallyregulated lipolysis -AKAP1, PRKAR2B -were down-regulated, whereas NPY1R was up-regulated ( [6] . However, new criteria are under discussion [14] andmaychangetheassignment.Themechanismsunderlying themetabolicsyndromearenotwell understood.Currentevidence supports that the accumulation of abdominal fat is a major determinant of the metabolic syndrome, while gluteofemoralbodyfatseemstoexertaprotectiverole [15] .Upper-bodysubcutaneousfatisthedominantcontributortocirculating free fatty acids and the main source of excess fatty acid release in upper-body obesity and of abnormalities in subcutaneous lipolysis, which appears to be an important cause of peripheral insulin resistance [16] , possibly through altering fat storage and the expression of TNF-a by adipocytes in visceral fat [17] . We investigated the differential expression of genes encoding proteins participating in lipid andlipoproteinmetabolisminadiposetissue.Themicroarray analysisrevealedthatseveraltranscriptsinvolvedinthestimulationoflipolyticpathwayweredown-regulatedinobesebut not in lean subjects. Among them is the regulatory subunit typeIIbofPKA(PRKAR2B)whichplaysacrucialandcentralroleintheregulationofenergyexpenditureandglucose andlipidmetabolism [18, 19] .Itsactivityisknowntobemodulatedbyitsspecificlocationinthecell,aprocessmediated by A-kinase anchoring proteins (AKAPs) [20] . In fact, AKAP1, identified as a major adipocyte protein kinase Abinding protein [21] , was down-regulated in obese subjects. We also found that the transcription of NPY1R, a powerful several transcripts related to TNF-a-induced lipolysis were down-regulated including Gi and CIDEA. In contrast, CES1, an adipocyte lipase involved in basal lipolysis, was up-regulated(table2).
Inaddition,severaltranscriptsinvolvedincholesteroland lipoprotein metabolism, e.g. APOE and ABCA, a cellular cholesteroltransporter,weredown-regulated(table2)while VLDLR was up-regulated in SCAAT in the obese subjects (table2).
mRNA Expression of Selected Genes Correlated with Several Features of the Metabolic Syndrome
Gene expression of CES1, NPY1R, AKAP1, VLDLR and APOE was analyzed for potential association with different cardiovascular risk markers (table 3) . A positive correlation wasfoundbetweenCES1mRNAexpressioninSCAATand waist circumference (r = 0.55; p = 0.032) and the waist-toheight ratio (r = 0.53; p = 0.044). Also, CES1 mRNA levels correlatedwithplasmaglucose(r=0.55;p=0.035)andtriglyceridelevels(r=0.73;p=0.002)andwiththecardiovascular riskfactortotal/HDLcholesterol(r=0.65;p=0.009).Apositive correlation was found between NPY1R mRNA expressioninSCAATandwaistcircumference(r=0.65;p=0.009) andthewaist-to-heightratio(r=0.55;p=0.035).Moreover, NPY1RmRNAlevelswereassociatedwiththecardiovascular riskindex(r=0.52;p=0.048).
NegativecorrelationswerefoundbetweenAPOEmRNA expressioninSCAATandBMI(r=-0.68;p=0.006),waist circumference(r=-0.61;p=0.015)aswellaswaist-to-height ratio(r=-0.58;p=0.023).APOEwasnegativelycorrelated withleptin(r=-0.56;p=0.030)andpositivelycorrelatedwith adiponectin (r = 0.52; p = 0.049). Moreover, APOE mRNA levels were inversely correlated with the cardiovascular risk index (r = -0.65; p = 0.009) (table 3) and also with diastolic bloodpressure(r=-0.62;p=0.014).
AKAP1 mRNA levels were only significantly correlated withthewaist-to-heightratio(-0.59;p=0.016)whilenosignificant associations were found between VLDLR mRNA levelsandmetabolicsyndromefeatures. teroltransfer.Infact,thestudyofHuangetal. [38] suggested that these changes in adipose tissue APOE expression have significantimpactonadiposetissuelipidfluxandlipoprotein metabolism [38] .Thesedataandourpresentobservationsin humanadiposetissuesuggestthatadiposeAPOEmayparticipateindefendingadiposetissueandorganismalenergyhomeostasisinresponsetohighfatfeeding.IncontrasttoAPOE, VLDLR,anothergenerelatedwithcholesteroltransport,was up-regulated. It is well known that high levels of plasma VLDL are associated with obesity, type 2 diabetes [42, 43] andcardiovasculardisease [44] .Moreover,VLDLRcan playa role in the delivery of VLDL-TG-derived free fatty acids to adipose tissue,modulatingcirculatinglevelsofTGandVLDL [45, 46] .Indeed,VLDLR-/-micewereprotectedfromhighfat diet-induced obesity showing a decreased adipocyte size [47] and triglyceride storage in the adipocyte compared to wild-type counterparts [46, 48] . Interestingly, a positive correlationbetweenCES1andVLDLRmRNAlevelswasfound (datanotshown).
In the present study, whole adipose tissue was used for geneexpressionprofileanalysis,evenifthistissueonlyprovidesamixtureofcells(stroma-vascularcellsandadipocytes). Aninterestingquestiontobeanswerediswhichofthesecell fractionsaremainlycontributingtotheobservedgeneexpressionchangesinadiposetissue.RegardingCES1,severalpreviousstudieshaveobservedthatCES1expressionishigherin isolated adipocytes compared to intact adipose tissue [31] . PreviousstudieshavealsoshownthatAPOEmRNAisfound in differentiated 3T3-L1 adipocytes as well as in biopsies of humanadiposetissue,butnotinundifferentitated3T3-L1ad-ipocytes [49] ,suggestingthatthemaincontributioninAPOE gene expression observed in adipose tissue from obese subjects could come from the adipocytes. However, another studydescribedthatAPOEisalsodown-regulatedinadipose tissue-recruitedmacrophagesduringhigh-fatdietwhencomparedwithresidentmacrophages [50] .Inanycase,itisimportant to emphasize that information obtained about differentialgeneexpressionfromthetissueasawholeisrelevant.Indeed, total adipose tissue has been widely used to identify genesassociatedwithobesityusingDNAmicroarrays [51, 52] .
During the last years many efforts have been made to defineandsearchforgenesassociatedwithobesityandmetabolicsyndrome.Inthiscontext,severalstudieshaveaimedto lookforgenesdifferentiallyexpressedinadiposetissuefrom lean and obese subjects [23, 53] . The main novelty of the presentstudyarisefromthefactthatitwasdesignedtolook foradiposetissuegenesconferringsusceptibilityorresistance todevelopobesityandmetabolicsyndromeintwowellcharacterizedgroupsofsubjects.Despitelivinginsameenvironmentalconditions(habitualhighfatdietaryintakeandsimilar moderate physical activity), one group was resistant to gain weightandtodevelopmetabolicsyndromefeatures,whilethe other was susceptible to develop obesity and its associated metaboliccomplications.
antilipolyticagent [22] ,wasup-regulatedinSCAATofobese patients,whichisinaccordancewithapreviousstudywherea similar up-regulation was found in omental adipose tissue [23] . These data agree with those of several studies, which haveshownthatobesityisassociatedwithanimpairedcatecholamine-induced lipolysis and a reduced HSL and ATGL expression in adipocytes [24, 25] . However, elevated basal lipolysis has been observed in obese individuals which is related to the bigger fat cell size and to increased levels of proinflammatorycytokinesinadiposetissue [26, 27] .
Moreover, in our study a down-regulation of Gia and CIDEA in obese subjects was found. CIDEA has been assumedtohaveaspecificroleinlipolysisinwhitehumanfat cells mediated by cross-talk with TNF-a [28] . Thus, the elevatedbasallipolysisobservedinobesityimpliesthatotherTG lipasesmaybeup-regulated.Ourstudyrevealedthattheadipocytelipasecarboxylesterase1(CES1)anorthologueofcarboxylesterase3(alsonamedTGH2),whichwasfirstdescribed bySonietal [29] ,wasup-regulatedinobesesubjects,whichis inagreementwithotherstudies [30, 31] .Thislipaseishighly expressed in adipocytes and is transcriptionally regulated in response to changes in nutritional con ditions, suggesting a relevantroleinlipolyticresponsetoextendedfastinginadipocytes [32] . In our study, the positive association between CES1 and obesity was further supported by the fact that CES1mRNAexpressionwaspositivelycorrelatedwithwaist circumference, a recognized marker of adiposity and dyslipidemia [33] , and with the waist-to-height ratio, a useful predictor of coronary heart disease risk factor [34] . In addition, the positive correlation between CES1 mRNA expression and total/HDL cholesterol ratio, a known factor for cardiovascular risk, suggests that CES1 could play a role in theimpairedbasallipolysisinSCAATfromobeseindividuals. However, a recent publication has found no correlation between CES1 expression and lipolytic activity in isolated humanadipocytes [31] .
Ontheotherhand,theimpairedcapacityforthesensingof thereplenishmentoftheirlipidstoresbyadipocyteswhichresultsinalterationsinthebufferingcapacityofadiposetissue has been suggested as the cause of metabolic syndrome [5, 35] .Basedonthefactthattriacylglycerolandcholesterolstorage are closely linked in adipocytes, it has been postulated thatcholesterolmightparticipateintheintracellularsensing forfatcellsizeandtriacylglycerolcontent [36, 37] .OurmicroarrayandRT-PCRanalysisshowedadown-regulationofthe APOEgeneinobesesubjects.Thisisinaccordancewiththe markedsuppressionofadiposeAPOEobservedinbothdietinduced and genetic (ob/ob mice) models of obesity [38] . A recent study evidenced that excess fat accumulation via an APOE-dependentpathway mightplayaroleindevelopment of the metabolic syndrome [39] . APOE is secreted by cells withhighlipidefflux,andithasbeenshowntobeexpressed highlyinadiposetissue [40, 41] .Inthesecells,APOE modulates cellular cholesterol metabolism by facilitating cholesObesFacts2010;3:312-318 DysregulationinAdiposeLipidMetabolism GenesandObesity 317 Acknowledgements WearegratefultoMs.VeronicaCiaurrizforherhelp;wealsogratefully acknowledge the receipt of funding from the Government of Navarra (Health Department) and the Linea Especial of the University of Navarra(LE/97).
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In summary, our data show a different expression of adipose transcripts encoding for proteins involved in lipolysis andlipoproteinmetabolisminsubjects'resistant'or'susceptible' to develop high-fat diet-induced obesity. These results, takenasawhole,suggestthatthechangesintheexpression levelsoftheseadiposetissuegenesmayhavesignificantimpactonadiposetissuelipolysisrateaswellasonlipidfluxand lipoprotein metabolism. Nevertheless, the molecular mechanisms underlying the control of these key lipid metabolism processesarestillnotfullyunderstood.Ourdataalsosuggest thatCES1,arecentlydiscoveredlipase,andAPOEcouldplay a role in obesity-associated cardiovascular risk factors and mightbepromising targetsinmetabolicsyndrometreatment.
